Suppression of hormone-refractory prostate cancer by a novel nuclear factor κB inhibitor in nude mice

Cancer Research

Volumn 63, Issue 1, 2003, Pages 107-110

  Kikuchi, Eiji ^a   Horiguchi, Yutaka ^a   Nakashima, Jun ^a   Kuroda, Kenji ^a   Oya, Mototsugu ^a   Ohigashi, Takashi ^a   Takahashi, Nozomu ^a   Shima, Yutaka ^a   Umezawa, Kazuo ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOEPOXYDONE; CYTOTOXIC AGENT; DEXAMETHASONE; GLIOTOXIN; I KAPPA B; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PANEPOXYDONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG BINDING; DRUG SYNTHESIS; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BENZAMIDES; CELL DIVISION; CYCLOHEXANONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; HUMANS; KINETICS; MALE; MICE; MICE, NUDE; NF-KAPPA B; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0037227989     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chung, T. D., Yu, J. J., Spiotto, M. T., Bartkowski, M., and Simons, J. W. Characterization of the role of IL-6 in the progression of prostate cancer. Prostate. 38: 199-207, 1999.
2. Nakajima, Y., DelliPizzi, A. M., Mallouh, C., and Ferreri, N. R. TNF-mediated cytotoxicity and resistance in human prostate cancer cell lines. Prostate, 29: 296-302, 1996.
3. Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., and Murai, M. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin. Cancer Res., 6: 2702-2706, 2000.
4. Baeuerle, P. A., and Baltimore, D. NF-κB: ten years after. Cell. 87: 13-20, 1996.
5. Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N., and Price, B. D. Constitutive activation of IκB kinase a and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene. 18: 7389-7394, 1999.
6. Sumitomo, M., Tachibana, M., Nakashima, J., Murai, M., Miyajima, A., Kimura, F., Hayakawa, M., and Nakamura, H. An essential role for nuclear factor κ B in preventing TNF-α-induced cell death in prostate cancer cells. J. Urol., 161: 674-679, 1999.
7. Muenchen, H. J., Lin, D. L., Walsh, M. A., Keller, E. T., and Pienta, K. J. Tumor necrosis factor-α-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-κB by an IκBα "super-repressor". Clin. Cancer Res., 6: 1969-1977, 2000.
8. Matsumoto, N., Iinuma, H., Sawa, T., Takeuchi, T., Hirano, S., Yoshioka, T., and Ishizuka, M. Epoxyquinomicins A. B. C and D, new antibiotics from Amycolatopsis. II. Effect on type II collagen-induced arthritis in mice. J. Antibiot. (Tokyo), 50: 906-911, 1997.
9. Erkel, G., Anke, T., and Sterner, O. Inhibition of NF-κB activation by panepoxydone. Biochem. Biophys. Res. Commun., 226: 214-221, 1996.
10. Matsumoto, N., Ariga, A., To-e, S., Nakamura, H., Agata, N., Hirano, S., Inoue, J., and Umezawa, K. Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C. Bioorg. Med. Chem. Lett., 10: 865-869, 2000.
11. Ariga, A., Namekawa, J., Matsumoto, N., Inoue, J., and Umezawa, K. Inhibition of tumor necrosis factor-α-induced nuclear translocation and activation of NF-κB by dehydroxymethylepoxyquinomicin. J. Biol. Chem., 277: 24625-24630, 2002.
12. Muraki, J., Addonizio, J. C., Choudhury, M. S., Fischer, J., Eshghi, M., Davidian, M. M., Shapiro, L. R., Wilmot, P. L., Nagamatsu, G. R., and Chiao, J. W. Establishment of new human prostatic cancer cell line (JCA-1). Urology, 36: 79-84, 1990.
13. Nakashima, J., Brookins, J., Beckman, B., and Fisher, J. W. Increased erythropoietin secretion in human hepatoma cells by N6-cyclohexyladenosine. Am. J. Physiol., 261: C455-460, 1991.
14. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Wash. DC), 274: 787-789, 1996.
15. Beg, A. A., and Baltimore. D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Wash. DC), 274: 782-784, 1996.
16. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Wash. DC). 267: 1485-1488, 1995.
17. Oya, M., Ohtsubo, M., Takayanagi, A., Tachibana, M., Shimizu, N., and Murai, M. Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene. 20: 3888-3896, 2001.
18. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (Wash. DC). 270: 286-290, 1995.
19. Kopp, E., and Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science (Wash. DC), 265: 956-959, 1994.
20. Gehrt, A., Erkel, G., Anke, T., and Sterner, O. Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1, 3-dienylbenzene, new inhibitors of eukaryotic signal transduction. J. Antibiot. (Tokyo), 51: 455-463, 1998.
21. Pahl, H. L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E. B., Vogt, M., Myers, C., Parks, T., Warring, P., Muhlbacher, A., Czernilofsky, A. P., and Baeuerle, P. A. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med., 183: 1829-1840, 1996.
22. van Bokhoven, A., Varella-Garcia, M., Korch, C., and Miller, G. J. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res., 61: 6340-6344, 2001.